Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? Andrew LeaskSunil K. ParapuramD. J. Abraham Review Open access 21 January 2009 Pages: 89 - 94
Connective tissue growth factor(CCN2), a pathogenic factor in diabetic nephropathy. What does it do? How does it do it? Roger M. Mason Review Open access 14 February 2009 Pages: 95 - 104
Normal growth and development in mice over-expressing the CCN family member WISP3 Yukio NakamuraYajun CuiMatthew L. Warman Research Article Open access 29 April 2009 Pages: 105 - 113
CCN3: a key growth regulator in Chronic Myeloid Leukaemia Lynn McCallumWanhua LuAlexandra E. Irvine OriginalPaper Open access 22 July 2009 Pages: 115 - 124
Periostin localizes to cells in normal skin, but is associated with the extracellular matrix during wound repair Linda Jackson-BoetersWeiyan WenDouglas W. Hamilton Research Article Open access 19 June 2009 Pages: 125 - 133
CCN3 and bone marrow cells Ken-ichi KatsubeSaki IchikawaAkira Yamaguchi OriginalPaper Open access 23 July 2009 Pages: 135 - 145
A rapid and sensitive method for measuring cell adhesion Wanhua LuLynn McCallumAlexandra E. Irvine Research Article Open access 16 April 2009 Pages: 147 - 149
What’s in an intron? CCN1 mRNA splicing in cancer Andrew Leask Bits and Bytes Open access 21 April 2009 Pages: 151 - 152
Alternative splicing of CCN mRNAs …. it has been upon us Bernard Perbal Bits and Bytes Open access 28 April 2009 Pages: 153 - 157
Death of a tumor: targeting CCN in pancreatic cancer Andrew Leask Bits and Bytes Open access 08 March 2009 Pages: 159 - 160
Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2 Andrew Leask Bits and Bytes Open access 29 May 2009 Pages: 161 - 162